A stabilised growth-hormone-releasing hormone analog and the only approved GH secretagogue. Approved specifically to reduce excess visceral fat in HIV-associated lipodystrophy.
FDA-approved (Egrifta) for HIV-associated lipodystrophy.
Ranges compiled from published protocols, not a clinical guideline. Convert a dose into syringe units with the dosage calculator.
This page summarises how much a compound has been studied. A high publication count is not evidence that something works, is safe, or is legal to obtain where you live. Consult a qualified healthcare provider before acting on anything here.
Our mission is to make peptide research clear, credible, and usable for people who refuse to rely on hype.